Issue of Equity

22 Jun 2005 16:19

Akers Biosciences, Inc.22 June 2005 Akers Biosciences, Inc. Issue of Shares Akers Biosciences, Inc. today announces that on 7 June 2005 it approved theissue of 111,624 shares of common stock, no par value ("Common Stock") to threevendors, who have elected to convert their amounts due from the Company toshares. The transactions allow the Company to remove $116,150 from tradeaccounts payable and render that amount as part of its permanent capital. Theaverage price per share for these transactions was 56 pence, ($1.04). Application has been made to the London Stock Exchange for the 111,624 CommonShares to be admitted to trading, such admission expected to take place on 23June 2005. Contact Paul B. Freedman - 001 856 848 2116. END This information is provided by RNS The company news service from the London Stock Exchange